News

BMJ6d
Early clinical surrogates for outcome prediction after stroke thrombectomy in daily clinical practice
Background and purpose To investigate early clinical surrogates for long-term independency of patients treated with thrombectomy for large vessel occlusion stroke in daily clinical routine. Methods ...
BMJ1d
Late onset startle induced tics
Dr Marina A J Tijssen, MRC Human Movement and Balance Unit, Institute of Neurology, Queen Square, London WC1N 3BG, UK. email M.Koning-Tijssen{at}ion.ucl.ac.uk Three cases of late onset Gilles de la ...
BMJ1d
Differentiating lower motor neuron syndromes
1 Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Lower motor neuron (LMN) syndromes typically present with muscle wasting and weakness and ...
BMJ2d
Yawning in acute anterior circulation stroke
Institute for Neuroradiology, JW Goethe-University Frankfurt am Main, Frankfurt, Germany Dr Oliver Singer, Department of Neurology, JW Goethe-University Frankfurt am Main, Schleusenweg 2-16, D-60528 ...
BMJ2d
P109 Experience of tunnelled vs. bolt EVDs on the intensive care unit
Objectives The placement of an external ventricular drain (EVD) is a common neurosurgical operation that carries great benefit in acute hydrocephalus but is not without risk. In our centre, bolt EVDs ...
BMJ2d
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
Objective The Tysabri Observational Programme (TOP), which began >10 years ago, is an open-label, multinational, prospective observational study evaluating the long-term safety and effectiveness of ...
BMJ5d
Intraoperative microvascular Doppler ultrasonography in cerebral aneurysm surgery
a Department of Neurosurgery, Benjamin Franklin Medical Center, Free University of Berlin, Hindenburgdamm 30, 12200 Berlin, Germany, b Department of Radiology Dr Ruediger Stendel, Department of ...
BMJ4d
A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
Correspondence to Dr Christine Lo, Department of Clinical Neurosciences, University of Oxford Nuffield, Oxford OX1 1NF, Oxfordshire, UK; christine.lo{at}nhs.net Background An unmet need remains for ...
BMJ2d
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies
Background To evaluate the efficacy of rituximab in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients not responding to conventional immune therapies. Methods An open-label, ...
BMJ6d
Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias
Correspondence to Professor Ammar Al-Chalabi, Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London SE5 9RX, UK; ...
BMJ4d
Prevalence, incidence and clinical features of neuromyelitis optica spectrum disorders in northern Japan
Correspondence to Dr Masaaki Niino, Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo 063-0005, Japan; niino.masaaki.tc{at}mail.hosp.go.jp Neuromyelitis ...
BMJ5d
Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis
Objective It has been debated whether the different clinical disease courses in multiple sclerosis (MS) are the consequence of different pathogenic mechanisms, with distinct risk factors, or if all MS ...